CDC COVID-19 Response Team.
US Public Health Service Commissioned Corps, Rockville, Maryland.
Pediatrics. 2022 Jan 1;149(1). doi: 10.1542/peds.2021-053418. Epub 2021 Dec 22.
Describe population-based rates and risk factors for severe coronavirus disease 2019 (COVID-19) (ie, ICU admission, invasive mechanical ventilation, or death) among hospitalized children.
During March 2020 to May 2021, the COVID-19-Associated Hospitalization Surveillance Network identified 3106 children hospitalized with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection in 14 states. Among 2293 children primarily admitted for COVID-19, multivariable generalized estimating equations generated adjusted risk ratios (aRRs) and 95% confidence intervals (CIs) of the associations between demographic and medical characteristics abstracted from medical records and severe COVID-19. We calculated age-adjusted cumulative population-based rates of severe COVID-19 among all children.
Approximately 30% of hospitalized children had severe COVID-19; 0.5% died during hospitalization. Among hospitalized children aged <2 years, chronic lung disease (aRR: 2.2; 95% CI: 1.1-4.3), neurologic disorders (aRR: 2.0; 95% CI: 1.5‒2.6), cardiovascular disease (aRR: 1.7; 95% CI: 1.2‒2.3), prematurity (aRR: 1.6; 95% CI: 1.1‒2.2), and airway abnormality (aRR: 1.6; 95% CI: 1.1‒2.2) were associated with severe COVID-19. Among hospitalized children aged 2 to 17 years, feeding tube dependence (aRR: 2.0; 95% CI: 1.5‒2.5), diabetes mellitus (aRR: 1.9; 95% CI: 1.6‒2.3) and obesity (aRR: 1.2; 95% CI: 1.0‒1.4) were associated with severe COVID-19. Severe COVID-19 occurred among 12.0 per 100 000 children overall and was highest among infants, Hispanic children, and non-Hispanic Black children.
Results identify children at potentially higher risk of severe COVID-19 who may benefit from prevention efforts, including vaccination. Rates establish a baseline for monitoring changes in pediatric illness severity after increased availability of COVID-19 vaccines and the emergence of new variants.
描述住院儿童中严重 2019 年冠状病毒病(COVID-19)(即 ICU 入院、有创机械通气或死亡)的基于人群的发生率和危险因素。
在 2020 年 3 月至 2021 年 5 月期间,COVID-19 相关住院监测网络在 14 个州确定了 3106 名因实验室确诊的严重急性呼吸综合征冠状病毒 2 感染住院的儿童。在 2293 名主要因 COVID-19 入院的儿童中,从病历中提取的人口统计学和医学特征的多变量广义估计方程生成了严重 COVID-19 与人口统计学和医学特征之间关联的调整风险比(aRR)和 95%置信区间(CI)。我们计算了所有儿童中严重 COVID-19 的年龄调整后基于人群的发生率。
约 30%的住院儿童患有严重 COVID-19;住院期间有 0.5%的儿童死亡。在年龄<2 岁的住院儿童中,慢性肺部疾病(aRR:2.2;95%CI:1.1-4.3)、神经系统疾病(aRR:2.0;95%CI:1.5-2.6)、心血管疾病(aRR:1.7;95%CI:1.2-2.3)、早产(aRR:1.6;95%CI:1.1-2.2)和气道异常(aRR:1.6;95%CI:1.1-2.2)与严重 COVID-19 相关。在年龄 2 至 17 岁的住院儿童中,需要依赖喂养管(aRR:2.0;95%CI:1.5-2.5)、糖尿病(aRR:1.9;95%CI:1.6-2.3)和肥胖(aRR:1.2;95%CI:1.0-1.4)与严重 COVID-19 相关。总体而言,每 100000 名儿童中有 12.0 例发生严重 COVID-19,其中婴儿、西班牙裔儿童和非西班牙裔黑人和西班牙裔儿童的发生率最高。
结果确定了患有严重 COVID-19 的潜在高风险儿童,他们可能受益于预防措施,包括疫苗接种。这些数据为监测 COVID-19 疫苗广泛应用后儿科疾病严重程度的变化以及新变异出现提供了基线。